APA (7th ed.) Citation

Benslimane, N., Loret, C., Chazelas, P., Favreau, F., Faye, P., Lejeune, F., & Lia, A. (2024). Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons. Pharmaceuticals (14248247), 17(3), 314. https://doi.org/10.3390/ph17030314

Chicago Style (17th ed.) Citation

Benslimane, Nesrine, Camille Loret, Pauline Chazelas, Frédéric Favreau, Pierre-Antoine Faye, Fabrice Lejeune, and Anne-Sophie Lia. "Readthrough Activators and Nonsense-Mediated MRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons." Pharmaceuticals (14248247) 17, no. 3 (2024): 314. https://doi.org/10.3390/ph17030314.

MLA (9th ed.) Citation

Benslimane, Nesrine, et al. "Readthrough Activators and Nonsense-Mediated MRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons." Pharmaceuticals (14248247), vol. 17, no. 3, 2024, p. 314, https://doi.org/10.3390/ph17030314.